Marshall Wace, LLP Tff Pharmaceuticals, Inc. Transaction History

Marshall Wace, LLP

  • $77.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$6.86 - $9.65 $81,983 - $115,327
-11,951 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$7.21 - $10.49 $86,166 - $125,365
11,951 New
11,951 $92,000
Q2 2021

Aug 13, 2021
SELL
$8.48 - $13.61 $483,122 - $775,388
-56,972 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$12.96 - $19.75 $738,357 - $1.13 Million
56,972 New
56,972 $773,000

Others Institutions Holding TFFP

# of Institutions
1
Shares Held
1M
Call Options Held
0
Put Options Held
0
View Full List

About TFF Pharmaceuticals, Inc.

TFFP Quotes by TradingView
  • Ticker TFFP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,477,800
  • Market Cap $8.92M
  • Description
  • TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...
More about TFFP
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email